Changlian Holdings and Waigaoqiao jointly establish a pharmaceutical company.

According to the QiChaCha App, Shanghai Changlian Baifu Pharmaceutical Co., Ltd. was established recently with a registered capital of 50 million RMB. Its business scope includes: pharmaceutical import and export, food sales, bonded warehouse operation, and customs supervised goods storage services. Equity penetration data on QiChaCha shows that the company is jointly owned by Changlian Holdings and Shanghai Waigaoqiao Biopharmaceutical Industry Development Co., Ltd., a wholly-owned subsidiary of Waigaoqiao.